Original language | English |
---|---|
Pages (from-to) | 489-489 |
Journal | EUROPEAN JOURNAL OF NEUROLOGY |
Volume | 26 |
Publication status | Published - 2019 |
Event | 5th Congress of the European-Academy-of-Neurology (EAN) - Oslo, NORWAY Duration: 29 Jun 2019 → 2 Jul 2019 |
Initial real-life experience with ocrelizumab in patients with relapsing-remitting and primary progressive multiple sclerosis in Salzburg, Austria
J Feige, Tobias Moser, Z Nagy, Ferdinand Otto, Peter Wipfler, Eugen Trinka, Johann Sellner
Research output: Contribution to journal › Abstract (Journal) › peer-review